Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
for adults, it is unclear whether ssris affect the risk of suicidality.
for children, adolescents, and probably young adults between 18 and 24 years old, there is a higher risk of both suicidal ideations and suicidal behavior in those treated with ssris.
furthermore in one of the studies the relation between suicidality risk in relation to the indication was investigated.
nadalje je ena izmed teh raziskav obravnavala povezavo med indikacijo in tveganjem za samomorilnost.
in addition, the suicidality should be monitored, as depression and mood liability are part of the reported aes for actiq.
poleg tega je potrebno spremljati tudi pojav samomorilnosti, saj sta depresija in spremembe razpoloženja navedena kot neželena učinka za zdravilo actiq.
results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.
izsledki epidemiološke raziskave niso pokazali povečanega tveganja za samomor pri bolnikih z bipolarno motnjo, ki so se zdravili z aripiprazolom v primerjavi z drugimi antipsihotiki.
results of an epidemiological study suggested that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among adult patients with schizophrenia or bipolar disorder.
izsledki epidemiološke raziskave niso pokazali povečanega tveganja za samomor pri odraslih bolnikih s shizofrenijo ali z bipolarno motnjo, ki so se zdravili z aripiprazolom v primerjavi z drugimi antipsihotiki.
results from observational studies indicate no increased risk of suicidality in patients who were prescribed paroxetine and likewise, post marketing reports indicate low rates of suicidal related behaviours.
podobno tudi poročila po uvedbi zdravila na trg kažejo na nizke stopnje s samomorilnostjo povezanega vedenja.
in accordance to the results, the association between suicidality risk and paroxetine appears significant only among patients with previous depression but not among patients with previous depression and anxiety or anxiety alone.
iz rezultatov sledi, da je tveganje za samomorilnost pomembno povezano z uporabo paroksetina le pri bolnikih s predhodno depresijo, ne pa tudi pri bolnikih s predhodno depresijo in tesnobo (anksiozo) ali samo tesnobo.
suicidal ideation and behaviours (suicidality) have been reported in patients treated with aeds in several indications, including epilepsy and bipolar disorder.
pri bolnikih, ki so bili zaradi različnih indikacij zdravljeni z antiepileptičnimi zdravili, vključno z epilepsijo in bipolarno motnjo, sta opisana samomorilno razmišljanje in vedenje (samomorilnost).
in patients with bipolar disorder, worsening of depressive symptoms and/ or the emergence of suicidality may occur whether or not they are taking medications for bipolar disorder, including lamictal.
pri bolnikih z bipolarno motnjo se lahko pojavi poslabšanje depresivnih simptomov in/ ali samomorilnost ne glede na to, ali jemljejo zdravila za bipolarno motnjo, vključno z zdravilom lamictal.
therefore patients receiving lamictal for bipolar disorder should be closely monitored for clinical worsening (including development of new symptoms) and suicidality, especially at the beginning of a course of treatment, or at the time of dose changes.
zato je treba bolnike, ki dobivajo zdravilo lamictal za bipolarno motnjo, natančno spremljati glede kliničnega poslabšanja (vključno s pojavom novih simptomov) in samomorilnosti, zlasti na začetku zdravljenja in v času spremembe odmerka.